Abstract:Objective: Acute kidney injury with metabolic acidosis is common in critically ill patients. This study assessed the associations between the use of IV sodium bicarbonate and mortality of patients with acute kidney injury and acidosis. Design: The study was conducted by using data from Beth Israel Deaconess Medical Center, which included several ICUs such as coronary care unit, cardiac surgery recovery unit, medical ICU, surgical ICU, and trauma-neuro ICU. Marginal structural Cox model was used to assess the relationship between receipt of sodium bicarbonate and hospital mortality, allowing pH, Paco(2), creatinine, and bicarbonate concentration as time-varying predictors of sodium bicarbonate exposure while adjusting for baseline characteristics of age, gender, Sequential Organ Failure Assessment score, acute kidney injury stage, Elixhauser score, quick Sequential Organ Failure Assessment, and Simplified Acute Physiology Score II. Setting: A large U.S.-based critical care database named Medical Information Mart for Intensive Care. Patients: Patients with Kidney Disease: Improving Global Outcomes acute kidney injury stage greater than or equal to 1 (> 1.5 baseline creatinine) and one measurement of acidosis (pH <= 7.2). Baseline creatinine was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation. Interventions: None. Measurements and Main Results: Of the 3,406 eligible patients, 836 (24.5%) had received sodium bicarbonate treatment. Patients who received sodium bicarbonate treatment had a higher Sequential Organ Failure Assessment (9 vs 7; p < 0.001), lower pH (7.16 vs 7.18; p < 0.001), and bicarbonate concentration (16.51 +/- 7.04 vs 20.57 +/- 6.29 mmol/L; p < 0.001) compared with those who did not receive sodium bicarbonate. In the marginal structural Cox model by weighing observations with inverse probability of receiving sodium bicarbonate, sodium bicarbonate treatment was not associated with mortality in the overall population (hazard ratio, 1.16; 95% CI, 0.98-1.42; p = 0.132), but it appeared to be beneficial in subgroups of pancreatitis (hazard ratio, 0.53; 95% CI, 0.28-0.98; p = 0.044) and severe acidosis (pH < 7.15; hazard ratio, 0.75; 95% CI, 0.58-0.96; p = 0.024). Furthermore, sodium bicarbonate appeared to be beneficial in patients with severe bicarbonate deficit (< -50 kg center dot mmol/L). Conclusions: In the analysis by adjusting for potential confounders, there is no evidence that IV sodium bicarbonate is beneficial for patients with acute kidney injury and acidosis. Although the study suggested potential beneficial effects in some highly selected subgroups, the results need to be validated in experimental trials.

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study

Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease

Sodium Bicarbonate Treatment and Clinical Outcomes in Chronic Kidney Disease with Metabolic Acidosis: A Meta-Analysis

Association Between the Use of Sodium Bicarbonate and Mortality in Acute Kidney Injury Using Marginal Structural Cox Model

The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial

Metabolic Acidosis in CKD: Pathogenesis, Adverse Effects, and Treatment Effects

Risk Potential for Organ Dysfunction Associated with Sodium Bicarbonate Therapy in Critically Ill Patients with Hemodynamic Worsening

Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis

The choice of dialysate bicarbonate: do different concentrations make a difference?

Effectiveness of Sodium Bicarbonate Infusion on Mortality in Septic Patients with Metabolic Acidosis

Reno-protective Effects of Oral Alkalizing Agents in Chronic Kidney Disease with Aciduria: Protocol for a Randomized Cohort Study

A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?

Five-Year Follow-Up of Patients With Radio-Contrast-Induced Acute Renal Injury: Can Intravenous Sodium Bicarbonate Improve Long-Term Outcomes?

Impact of Sodium Bicarbonate Supplementation on Serum Alpha Klotho in Chronic Kidney Disease Patients

The Ef Fi Cacy of Sodium Bicarbonate in Preventing Contrast-Induced Nephropathy in Patients with Pre-Existing Renal Insuf Fi Ciency : a Meta-Analysis

Outcomes after angiography with sodium bicarbonate and acetylcysteine

Effect of time-dependent dialysate bicarbonate concentrations on acid–base and uremic solute kinetics during hemodialysis treatments

Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.

Evaluation of different sodium bicarbonate regimens for the prevention of contrast medium-induced nephropathy

Efficacy and safety of perioperative sodium bicarbonate therapy for cardiac surgery-associated acute kidney injury: a meta-analysis.